The intronic miRNAs hsa-miR-33a and hsa-miR-33b located within Srebp2 and Srebp1 genes, respectively, regulate cholesterol metabolism and modulate fatty acid β-oxidation and insulin signaling in the liver, which may be particularly relevant in the setting of metabolic syndrome [39]. The gene discussed is SREBF2; the disease is metabolic syndrome.